Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion

被引:0
|
作者
Zhao, Junshan [1 ]
Ma, Yingying [1 ]
Xin, Li [1 ]
Wang, Lijun [1 ]
Gao, Hongliang [1 ]
机构
[1] Hebei Childrens Hosp, Dept Intens Care Med Div 2, Shijiazhuang 050031, Peoples R China
关键词
Intravenous immunoglobulin; Coronary arteries; Kawasaki disease; Peripheral blood cells; MANAGEMENT;
D O I
10.1186/s13052-025-01891-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundKawasaki disease (KD) primarily affects young children and can lead to coronary artery lesions. Intravenous immunoglobulin (IVIG) treatment is essential; however, it may fail in 10-20% of cases, increasing the risk of complications. Complete blood count (CBC) tests can help assess disease severity and predict risks. This study investigated the impact of IVIG on peripheral blood cells, including neutrophil count, platelet-lymphocyte ratio, hemoglobin level, mean platelet volume (MPV), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), in children with KD complicated by coronary artery lesions (CALs). MethodsThis retrospective analysis included children diagnosed with typical KD. The neutrophil count, hemoglobin level, platelet-lymphocyte ratio, MPV, ESR, and CRP were compared between those with (CAL+) and without (CAL-) CALs during the acute phase, as well as at 7 days, 1 month, and 2 months after normalizing body temperature with IVIG. ResultsA total of 76 children with KD were analyzed, including 30 with CAL+. CAL+ and CAL- patients exhibited elevated neutrophil counts during the acute phase, with no significant differences (P > 0.05) between groups. After IVIG treatment, CAL- patients demonstrated a more pronounced reduction in neutrophil count (P < 0.05) than CAL+ patients. Hemoglobin levels differed significantly during the acute phase (P < 0.05) but were comparable post-treatment (P > 0.05) between CAL+ and CAL- patients. The platelet-lymphocyte ratio varied significantly between groups during the acute phase and 1-month post-treatment (P < 0.05). Mean ESR and CRP levels were significantly elevated at all time points in the CAL+ group compared with the CAL- group. No significant differences in MPV were observed between groups. ConclusionsAfter IVIG treatment, CAL- patients demonstrated a more important reduction in neutrophil count than CAL+ patients after IVIG. Pediatric patients with KD and CAL+ showed lower hemoglobin and platelet-lymphocyte ratio and higher ESR and CRP compared with CAL-, suggesting that they may serve as indicators for CAL in pediatric patients with KD.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Intravenous Immunoglobulin Alone for Coronary Artery Lesion Treatment of Kawasaki Disease A Randomized Clinical Trial
    Kuo, Ho-Chang
    Lin, Ming-Chih
    Kao, Chung-Chih
    Weng, Ken-Pen
    Ding, Yun
    Han, Zhi
    Chen, Chih-Jung
    Jan, Sheng-Ling
    Chien, Kuang-Jen
    Ko, Chun-Hsiang
    Lin, Chien-Yu
    Lei, Wei-Te
    Guo, Mindy Ming-Huey
    Yang, Kuender D.
    Sylvester, Karl G.
    Whitin, John C.
    Tian, Lu
    Chubb, Henry
    Ceresnak, Scott R.
    McElhinney, Doff
    Cohen, Harvey J.
    Ling, Xuefeng B.
    JAMA NETWORK OPEN, 2025, 8 (04)
  • [2] Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
    Bal, Aswine K.
    Prasad, Deepa
    Pamintuan, Maria Angela Umali
    Mammen-Prasad, Elizabeth
    Petrova, Anna
    PEDIATRICS AND NEONATOLOGY, 2014, 55 (05): : 387 - 392
  • [3] The Effects of Intravenous Immunoglobulin on Coronary Artery Abnormalities in Children With Kawasaki Disease
    Noori, Noor Mohammad
    Pezhhan, Ali
    Teimouri, Alireza
    IRANIAN HEART JOURNAL, 2022, 23 (01):
  • [4] Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
    Brogan, Robert J.
    Eleftheriou, Despina
    Gnanapragasam, James
    Klein, Nigel J.
    Brogan, Paul A.
    PEDIATRIC RHEUMATOLOGY, 2009, 7
  • [5] Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
    Robert J Brogan
    Despina Eleftheriou
    James Gnanapragasam
    Nigel J Klein
    Paul A Brogan
    Pediatric Rheumatology, 7
  • [6] The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
    Chang, Ling-Sai
    Lo, Mao-Hung
    Li, Sung-Chou
    Yang, Ming-Yu
    Hsieh, Kai-Sheng
    Kuo, Ho-Chang
    ONCOTARGET, 2017, 8 (02) : 2044 - 2052
  • [7] Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease
    Shao, Shuran
    Zhou, Kaiyu
    Liu, Xiaoliang
    Liu, Lei
    Wu, Mei
    Deng, Yuxin
    Duan, Hongyu
    Li, Yifei
    Hua, Yimin
    Wang, Chuan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (10): : E4210 - E4220
  • [8] Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status
    Qiu, Huixian
    He, Yuee
    Rong, Xing
    Ren, Yue
    Pan, Lulu
    Chu, Maoping
    Wu, Rongzhou
    Shi, Hongying
    POSTGRADUATE MEDICINE, 2018, 130 (04) : 442 - 447
  • [9] Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease
    Qin Lijun
    Saumu Tobbi Mweri
    Wang Hongwei
    Shi Hong
    Hu Xiufen
    Cheng Peixuan
    Current Medical Science, 2005, 25 (3) : 348 - 350
  • [10] Reevaluation of the Efficacy of Intravenous Gammaglobulin in the Prevention and Treatment of Coronary Artery Lesion in Kawasaki Disease
    覃丽君
    王宏伟
    施虹
    胡秀芬
    程佩萱
    华中科技大学学报(医学英德文版), 2005, (03) : 348 - 350